Study Finds Risk Of Rare Blood Clots After First AstraZeneca COVID-19 Shot, Much Less Likely After Second Dose

Reuters (7/28, Aripaka) reports, “AstraZeneca’s COVID-19 vaccine carries a small extra risk of rare blood clots with low platelets after the first dose and no extra risk after the second, a study led and funded by the drugmaker showed on Wednesday, after...